Kyo; Satoru
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kyo; Satoru.The latest application filed is for "telomelysin/gfp-expressing recombinant virus".
- Kyo; Satoru - Ishikawa JP
- Kyo; Satoru - Kanazawa JP
- Kyo; Satoru - Kanazawa-shi JP
| Patent | Date |
|---|---|
| Oncolytic virus replicating selectively in tumor cells Grant 8,163,892 - Fujiwara , et al. April 24, 2 | 2012-04-24 |
| Telomelysin/GFP-expressing recombinant virus Grant 7,943,373 - Fujiwara , et al. May 17, 2 | 2011-05-17 |
| Telomelysin/GFP-expressing recombinant virus App 20110111480 - FUJIWARA; TOSHIYOSHI ; et al. | 2011-05-12 |
| Oncolytic Virus Replicating Selectively In Tumor Cells App 20110044949 - FUJIWARA; Toshiyoshi ; et al. | 2011-02-24 |
| Anticancer Agent to Be Combined with Telomelysin App 20100150884 - Fujiwara; Toshiyoshi ; et al. | 2010-06-17 |
| Telomelysin/gfp-expressing Recombinant Virus App 20080032283 - Fujiwara; Toshiyoshi ; et al. | 2008-02-07 |
| Oncolytic virus replicating selectively in tumor cells App 20060239967 - Fujiwara; Toshiyoshi ; et al. | 2006-10-26 |
| Telomelysin/GFP-expressing recombinant virus App 20060067890 - Fujiwara; Toshiyoshi ; et al. | 2006-03-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 